Table 2 Associations of clinical risk factors for pancreatic cancer (PC) with miR-1290 and CA 19-9 levels.
From: Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer
PC (N = 159*) | miR-1290 (no. copies/μl) | p-value | CA 19-9 (U/ml) | p-value | ||||
|---|---|---|---|---|---|---|---|---|
N | % | Median | Q1–Q3 | Median | Q1–Q3 | |||
Low risk | 12 | 7.5 | 1158 | 710–1700 | ns | 413.05 | 30.265–1394 | ns |
Intermediate risk | 114 | 71.7 | 672 | 352–1452 | 294.6 | 97.45–1709.1 | ||
High risk | 33 | 20.8 | 744 | 480–2524 | 400 | 63.86–1276 | ||
HS (N = 267) | miR-1290 (no. copies/μl) | CA 19-9 (U/ml) | ||||||
N | % | Median | Q1–Q3 | Median | Q1–Q3 | |||
Low risk | 42 | 15.7 | 352 | 288–488 | ns | 4.2 | 2.5–7.6 | ns |
Intermediate risk | 195 | 73.0 | 372 | 277.2–500 | 4.3 | 2.4–8.3 | ||
High risk | 30 | 11.3 | 344 | 269.6–500 | 5.5 | 3.2–8.9 | ||
